More on AVTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+86.4% Growth)
- Ratings (9.2 Score)
- Holders

Upcoming Events

- Earnings (11/7/25 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Avalo Therapuetics (NQ:AVTX)
Delayed: 17.31 -0.27 (1.54%)
Prev. Close $17.58  
Open$17.19 
52 Wk High$0.01 
52 Wk Low$0.01 
Day High$18.35 
Day Low$17.06 
P/E N/A  
EPS$0.00 
Volume436,121 

Friends, Peers and Foes (?): BHVN, COLL, TRVI, ABBV, AMGN (more...)

Mar 6, 2026 10:05 AM Form SCHEDULE 13G Avalo Therapeutics, Inc. Filed by: FMR LLC
Mar 2, 2026 04:24 PM Form 4 Avalo Therapeutics, Inc. For: Feb 26 Filed by: VARKI PAUL
Mar 2, 2026 04:24 PM Form 4 Avalo Therapeutics, Inc. For: Feb 26 Filed by: Riley Jennifer
Mar 2, 2026 04:24 PM Form 4 Avalo Therapeutics, Inc. For: Feb 26 Filed by: Doyle Mittie
Mar 2, 2026 04:24 PM Form 4 Avalo Therapeutics, Inc. For: Feb 26 Filed by: Boyd Taylor
Mar 2, 2026 04:22 PM Form 4 Avalo Therapeutics, Inc. For: Feb 26 Filed by: Sullivan Christopher Ryan
Mar 2, 2026 04:21 PM Form 4 Avalo Therapeutics, Inc. For: Feb 26 Filed by: NEIL GARRY ARTHUR
Feb 24, 2026 04:48 PM Form SCHEDULE 13G Avalo Therapeutics, Inc. Filed by: MILLENNIUM MANAGEMENT LLC
Feb 24, 2026 09:13 AM TD Cowen on Avalo Therapeutics (AVTX): 'Risk/Reward Skewed To Significant Upside For AVTX-009 Phase II'
Feb 24, 2026 07:00 AM Avalo Therapeutics to Participate in Upcoming Investor Conferences
View All Articles

Entities mentioned with AVTX

View All Entities